Insider Trading History of Cloonan Michael

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Cloonan Michael since 2019. This trader's CIK number is 1704336. At the time of last reporting, Cloonan Michael was the President & CEO of Sionna Therapeutics, Inc.. (stock ticker symbol SION). Also see all insider trading activities at Sionna Therapeutics, Inc..

Note that in the past Cloonan Michael also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Sage Therapeutics, Inc. (SAGE) by Cloonan Michael

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 SAGE 0 $0 25,000 $4,375,000 25,000 $1,835,750

Yearly summary of insider trading at Sionna Therapeutics, Inc. (SION) by Cloonan Michael

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 SION 0 $0 50,000 $1,193,113 50,000 $305,499


Insider trading activities at 2 companies by Cloonan Michael:

1. Sage Therapeutics, Inc. (SAGE)

2. Sionna Therapeutics, Inc. (SION)

Table 1. Insider trading of Sage Therapeutics, Inc. (SAGE) by Cloonan Michael

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-05-22 SAGE Sale 25,000 175.00 4,375,000
2019-05-22 SAGE Option Ex 25,000 73.43 1,835,750

Table 2. Insider trading of Sionna Therapeutics, Inc. (SION) by Cloonan Michael

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-27 SION Sale 7,426 25.01 185,716
2025-08-26 SION Sale 17,574 24.96 438,647
2025-08-27 SION Option Ex 7,426 6.11 45,372
2025-08-26 SION Option Ex 17,574 6.11 107,377
2025-08-20 SION Option Ex 25,000 6.11 152,750
2025-08-20 SION Sale 25,000 22.75 568,750

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cloonan Michael (President & CEO of Sionna Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.